The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 79.
499. lappuse
... ( Rule 276 ) ; three copies in addition to this certified one must be filed ( Rule 253a ) , and of these three additional copies one must be a ribbon copy ( Rule 253f ) and all three must include an index of witnesses , an index of ...
... ( Rule 276 ) ; three copies in addition to this certified one must be filed ( Rule 253a ) , and of these three additional copies one must be a ribbon copy ( Rule 253f ) and all three must include an index of witnesses , an index of ...
516. lappuse
... rules relating to declaration which include signifi- cant changes are 205 ( a ) and 207. Rule 209 has been cancelled . The last sentence of Rule 205 ( a ) has been broadened to ex- pressly provide for presenting claims of a patent ...
... rules relating to declaration which include signifi- cant changes are 205 ( a ) and 207. Rule 209 has been cancelled . The last sentence of Rule 205 ( a ) has been broadened to ex- pressly provide for presenting claims of a patent ...
522. lappuse
... Rule 253 has been additionally amended in the interest of clari- fication to refer to the " certified transcript " instead of the “ original transcript . " Paragraph ( f ) of the amended rule further explains that when the record is in ...
... Rule 253 has been additionally amended in the interest of clari- fication to refer to the " certified transcript " instead of the “ original transcript . " Paragraph ( f ) of the amended rule further explains that when the record is in ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention